HInd EID

Dr. HInd EID


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2026 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
MRMoussa A. Riachy
Moussa A. Riachy
HEHInd EID
HInd EID
RHRichard N. Haouchan
Richard N. Haouchan
CMChristian Y. Matta
Christian Y. Matta
KKKarine J. Abou Khaled
Karine J. Abou Khaled
Cerebral venous air embolism is a rare but potentially fatal complication of central venous catheter insertion and removal. Although most venous air emboli

21 January 2026 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
BNBertha Maria Nassani
Bertha Maria Nassani
HEHInd EID
HInd EID
DMDenise Mourad
Denise Mourad
MRMoussa Riachy
Moussa Riachy
GMGeorges Maalouly
Georges Maalouly
Thrombotic thrombocytopenic purpura is a rare and life-threatening hematologic disorder. We present the case of a 66-year-old man who developed acquired th

3 June 2025 in Surgical Oncology
Verified
Journal Article
Open access
HEHInd EID
HInd EID
EKElias KARAM
Elias KARAM
AKAntoine El. Kik
Antoine El. Kik
FKFadi El Karak
Fadi El Karak
ACAmmar Chamaa
Ammar Chamaa
MRMoussa Riachy
Moussa Riachy
Mediastinal lymph node involvement is a prognostic factor in patients with localized NSCLC. Both ipsilateral and subcarinal nodal involvement are classified as N2 disease. However, there is no universally agreed-upon approach for diagnosing and treating this condition. The aim of this study is to elaborate an institutional N2 consensus. A multidisciplinary expert panel at Hotel Dieu de France provided informed consent to participate in the modified Delphi process. Twelve basic statements were started by a steering committee of three independent reviewers on the basis of international consensus, medical literature and personal experience. In the first round, physicians answered an open-ended questionnaire that was analyzed thematically. In the second round, the participants rated the generated statements and added their comments. In the third round, the participants rated their agreement via a 6-point Likert scale. Consensus was defined as ≥80 % agreement (A+ or A) with a statement. Nineteen physicians completed the three rounds. A full consensus was reached in eleven statements. Preoperative mediastinal staging is mandatory in patients with resectable N2 disease. It should be considered in patients with a high SUVmax (maximum standardized uptake value) (≥3), proximal or apical tumors and high carcinoembryonic antigen levels. Surgery is performed in the absence of neoadjuvant treatment depending on a single station with nonbulky disease and stage T3 invasive/T4 disease. In patients with N2 disease at several stations, radio chemotherapy is the main treatment, followed by durvalumab in patients with good general status. In pN2 patients, postsurgical treatment is based on the condition of the surgical resection margin. These findings will help physicians in multidisciplinary discussions agree on clinical decisions.